Vicki Goodman

Vicki Goodman

Hoofd Techniek/Wetenschap/O&O bij RECURSION PHARMACEUTICALS, INC.
57 jaar
Health Technology
Consumer Services
Government

Profiel

Vicki L.
Goodman
is currently Chief Medical Officer at Recursion Pharmaceuticals, Inc. since 2026.
Former positions include Chief Medical Officer at Mural Oncology Plc from 2023 to 2025, Chief Medical Officer and EVP-Product Development at Exelixis, Inc. from 2022 to 2023, VP-Clinical Research and Head-Therapeutic Area at Merck & Co., Inc. from 2020 to 2021, VP and Head-New Asset Development at Bristol Myers Squibb Co. from 2015 to 2020, and Medical Officer in the Oncology Division at the US Food & Drug Administration from 2004 to 2007.
Education includes undergraduate studies at Rutgers State University of New Jersey and a doctorate from Albert Einstein College of Medicine, Inc.

Actieve functies van Vicki Goodman

BedrijvenFunctieBegin
RECURSION PHARMACEUTICALS, INC. Hoofd Techniek/Wetenschap/O&O 06-04-2026

Eerdere bekende functies van Vicki Goodman

BedrijvenFunctieEinde
EXELIXIS, INC. Hoofd Techniek/Wetenschap/O&O 23-08-2023
MERCK & CO., INC. Hoofd Techniek/Wetenschap/O&O 01-12-2021
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01-05-2020
Corporate Officer/Principal 01-01-2007
Ervaring van Vicki Goodman in detail bekijken

Opleiding van Vicki Goodman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

66

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Government

Consumer Services

  1. Beurs
  2. Insiders
  3. Vicki Goodman